{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:36:49Z","timestamp":1775871409319,"version":"3.50.1"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Chronic systemic inflammation is associated with mortality in patients with chronic kidney disease, cardiovascular disease, and diabetes. The goal of this study was to examine the relationship between pretransplant inflammatory biomarkers (growth differentiation factor-15 [GDF-15], interleukin-6 [IL-6], soluble tumor necrosis factor receptor-1, monokine induced by gamma interferon\/chemokine [C-X-C motif] ligand 9 [MIG\/CXCL9], monocyte chemoattractant protein-1, soluble FAS, tumor necrosis factor-\u03b1, interleukin-15, and interleukin-1\u03b2) and death with function (DWF) after kidney transplantation (KT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We retrospectively measured inflammatory biomarker levels in serum collected up to 1 y before KT (time from blood draw to KT was 130\u2005\u00b1\u2005110 d) in recipients transplanted between January 2006 and December 2018. Kaplan-Meier estimation, Cox regression, and Gradient Boosting Machine modeling were used to examine the relationship between inflammatory biomarkers and DWF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Our cohort consisted of 1595 KT recipients, of whom 62.9% were male and 83.2% were non-Hispanic White. Over a mean follow-up of 7.4\u2005\u00b1\u20053.9 y, 21.2% of patients (n\u2005=\u2005338) experienced DWF. Patients with the highest quartile levels of GDF-15 (&gt;4766 pg\/mL), IL-6 (&gt;6.11 pg\/mL), and MIG\/CXCL9 (&gt; 5835 pg\/mL) had increased rates of DWF, and each predicted mortality independently of the others. When adjusted for clinical factors (age, diabetes, etc), the highest quartile levels of GDF-15 and IL-6 remained independently associated with DWF. Adding inflammatory markers to a clinical Cox model improved the C-statistic for DWF from 0.727 to 0.762 using a Gradient Boosting Machine modeling approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>These findings suggest that pre-KT serum concentrations of GDF-15, IL-6, and MIG\/CXCL9 may help to risk stratify and manage patients undergoing KT and suggests that chronic inflammation may play a role in mortality in KT recipients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005103","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:57:46Z","timestamp":1719259066000},"page":"2434-2445","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Increased Pretransplant Inflammatory Biomarkers Predict Death With Function After Kidney Transplantation"],"prefix":"10.1097","volume":"108","author":[{"given":"Elizabeth C.","family":"Lorenz","sequence":"first","affiliation":[{"name":"Section of Nephrology, Baylor College of Medicine, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron H.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter D.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Bentall","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atiya F.","family":"Dhala","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy D.","family":"Waterman","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie C.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LaTonya J.","family":"Hickson","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Rule","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Cheville","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan K.","family":"LeBrasseur","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Stegall","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, MN."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"e001962","DOI":"10.1136\/bmjdrc-2020-001962","article-title":"Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA.","volume":"9","author":"Harding","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MOT.0000000000001039","article-title":"How to maximize graft survival.","volume":"28","author":"Lim","year":"2023","journal-title":"Curr Opin Organ Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/ajt.12732","article-title":"Kidney allograft function and histology in recipients dying with a functioning graft.","volume":"14","author":"Lorenz","year":"2014","journal-title":"Am J Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"e1273","DOI":"10.1097\/TXD.0000000000001273","article-title":"Death with function and graft failure after kidney transplantation: risk factors at baseline suggest new approaches to management.","volume":"8","author":"Merzkani","year":"2022","journal-title":"Transplant Direct"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence.","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12887-015-0424-6","article-title":"Plasma levels of monokine induced by interferon-gamma\/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine\/chemokine (C-C motif) ligand 17 in children with Kawasaki disease.","volume":"15","author":"Feng","year":"2015","journal-title":"BMC Pediatr"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0264-410X(99)00513-7","article-title":"Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space.","volume":"18","author":"Franceschi","year":"2000","journal-title":"Vaccine"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies.","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"12539","DOI":"10.3390\/ijms222212539","article-title":"How immunosenescence and inflammaging may contribute to hyperinflammatory syndrome in COVID-19.","volume":"22","author":"Muller","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.3390\/cells10102562","article-title":"Inflammaging, an imbalanced immune response that needs to be restored for cancer prevention and treatment in the elderly.","volume":"10","author":"Serrano-Lopez","year":"2021","journal-title":"Cells"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ndt\/gfaa260","article-title":"Serum levels of IL-6, IL-8 and IL-10 and risks of end-stage kidney disease and mortality.","volume":"36","author":"Chen","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clinbiochem.2019.07.013","article-title":"Growth differentiation factor 15 is decreased by kidney transplantation.","volume":"73","author":"Connelly","year":"2019","journal-title":"Clin Biochem"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/TP.0000000000002213","article-title":"Frailty, inflammatory markers, and waitlist mortality among patients with end-stage renal disease in a prospective cohort study.","volume":"102","author":"McAdams-DeMarco","year":"2018","journal-title":"Transplantation"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1017\/S002966511300030X","article-title":"Inflammatory status in patients with different stages of chronic kidney disease.","volume":"72","author":"Tbahriti","year":"2013","journal-title":"P Nutr Soc"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000521781","article-title":"Growth differentiation factor 15 is superior to troponin I in the evaluation of kidney transplant candidates.","volume":"53","author":"de Cos Gomez","year":"2022","journal-title":"Am J Nephrol"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/jcm9051333","article-title":"Prognostic value of growth differentiation factor 15 in kidney donors and recipients.","volume":"9","author":"Jehn","year":"2020","journal-title":"J Clin Med"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"837575","DOI":"10.3389\/fragi.2022.837575","article-title":"Growth differentiation factor-15 in immunity and aging.","volume":"3","author":"Pence","year":"2022","journal-title":"Front Aging"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s43587-021-00082-y","article-title":"An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging.","volume":"1","author":"Sayed","year":"2021","journal-title":"Nat Aging"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"e133668","DOI":"10.1172\/jci.insight.133668","article-title":"The senescence-associated secretome as an indicator of age and medical risk.","volume":"5","author":"Schafer","year":"2020","journal-title":"JCI Insight"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2020.08.026","article-title":"Interleukin-1beta and risk of premature death in patients with myocardial infarction.","volume":"76","author":"Silvain","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11010-017-3054-5","article-title":"Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography.","volume":"435","author":"Tajfard","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s11357-022-00685-2","article-title":"Associations between biomarkers of cellular senescence and physical function in humans: observations from the lifestyle interventions for elders (LIFE) study.","volume":"44","author":"Fielding","year":"2022","journal-title":"Geroscience"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"e12706","DOI":"10.1111\/acel.12706","article-title":"Circulating levels of monocyte chemoattractant protein-1 as a potential measure of biological age in mice and frailty in humans.","volume":"17","author":"Yousefzadeh","year":"2018","journal-title":"Aging Cell"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"e14006","DOI":"10.1111\/acel.14006","article-title":"Biomarkers of cellular senescence and risk of death in humans.","volume":"22","author":"St Sauver","year":"2023","journal-title":"Aging Cell"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: a gradient boosting machine.","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann Statistics"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12882-019-1360-8","article-title":"Racial differences in inflammation and outcomes of aging among kidney transplant candidates.","volume":"20","author":"Shrestha","year":"2019","journal-title":"BMC Nephrol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"155759","DOI":"10.1016\/j.cyto.2021.155759","article-title":"Cytokines screening identifies MIG (CXCL9) for postoperative recurrence prediction in operated non-small cell lung cancer patients.","volume":"149","author":"Zhang","year":"2022","journal-title":"Cytokine"},{"key":"R30-20250604","first-page":"2642","article-title":"MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.","volume":"9","author":"Brown","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases.","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2017.12.014","article-title":"Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients.","volume":"316","author":"Detrick","year":"2018","journal-title":"J Neuroimmunol"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1002\/jmv.26654","article-title":"Defining IL-6 levels in healthy individuals: a meta-analysis.","volume":"93","author":"Said","year":"2021","journal-title":"J Med Virol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"592727","DOI":"10.3389\/fimmu.2021.592727","article-title":"Increased serum levels of soluble TNF-alpha receptor is associated with ICU mortality in COVID-19 patients.","volume":"12","author":"Mortaz","year":"2021","journal-title":"Front Immunol"},{"key":"R36-20250604","first-page":"186","article-title":"Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker.","volume":"21","author":"Lamana","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2249.1998.00569.x","article-title":"Elevated serum levels of soluble Fas\/APO-1 (CD95) in patients with hepatocellular carcinoma.","volume":"112","author":"Jodo","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bjo.84.1.103","article-title":"Serum levels of soluble Fas in patients with Graves\u2019 ophthalmopathy.","volume":"84","author":"Ohtsuka","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1155\/MI.2005.175","article-title":"Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction.","volume":"2005","author":"Arakelyan","year":"2005","journal-title":"Mediators Inflamm"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.0000049742.68848.99","article-title":"Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.","volume":"107","author":"de Lemos","year":"2003","journal-title":"Circulation"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5455\/msm.2022.33.40-43","article-title":"Serum levels of tumor necrosis factor - alpha in patients with psoriasis.","volume":"34","author":"Ovcina-Kurtovic","year":"2022","journal-title":"Mater Sociomed"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/en.2012-2138","article-title":"Circulating levels of IL-1B+IL-6 cause ER stress and dysfunction in islets from prediabetic male mice.","volume":"154","author":"O\u2019Neill","year":"2013","journal-title":"Endocrinology"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1515\/cclm-2022-0135","article-title":"Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort.","volume":"60","author":"Welsh","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint.","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/CIRCULATIONAHA.112.129437","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.","volume":"126","author":"Wang","year":"2012","journal-title":"Circulation"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jacc.2007.04.091","article-title":"Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.","volume":"50","author":"Kempf","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2018.03.025","article-title":"GDF-15, galectin 3, soluble ST2, and risk of mortality and cardiovascular events in CKD.","volume":"72","author":"Tuegel","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.2200641","article-title":"Emerging roles of growth differentiation factor 15 in immunoregulation and pathogenesis.","volume":"210","author":"Reyes","year":"2023","journal-title":"J Immunol"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40472-023-00393-6","article-title":"Cellular senescence and frailty in transplantation.","volume":"10","author":"Lorenz","year":"2023","journal-title":"Curr Transplant Rep"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1096\/fj.201900218R","article-title":"Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans.","volume":"34","author":"Yamane","year":"2020","journal-title":"FASEB J"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease.","volume":"77","author":"Barreto","year":"2010","journal-title":"Kidney Int"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/gerona\/glaa167","article-title":"Development and validation of an inflammatory-frailty index for kidney transplantation.","volume":"76","author":"Haugen","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function.","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.4049\/jimmunol.171.6.2812","article-title":"CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions.","volume":"171","author":"Rabin","year":"2003","journal-title":"J Immunol"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","article-title":"CXCR3 ligands in disease and therapy.","volume":"26","author":"Van Raemdonck","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.4049\/jimmunol.172.12.7417","article-title":"Chemokine monokine induced by IFN-gamma\/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.","volume":"172","author":"Whiting","year":"2004","journal-title":"J Immunol"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"e144455","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients.","volume":"6","author":"Abers","year":"2021","journal-title":"JCI Insight"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1182\/blood.V108.11.5040.5040","article-title":"Monokine induced by interferon-gamma (MIG) serum levels are a marker of disease load and correlate with prognosis in multiple myeloma.","volume":"108","author":"Schreder","year":"2006","journal-title":"Blood"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000371661","article-title":"High levels of soluble tumor necrosis factor receptors 1 and 2 and their association with mortality in patients undergoing hemodialysis.","volume":"5","author":"Carlsson","year":"2015","journal-title":"Cardiorenal Med"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"43520","DOI":"10.1038\/srep43520","article-title":"Circulating TNF receptors 1 and 2 predict mortality in patients with end-stage renal disease undergoing dialysis.","volume":"7","author":"Gohda","year":"2017","journal-title":"Sci Rep"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ageing\/afs175","article-title":"Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study.","volume":"42","author":"Luna","year":"2013","journal-title":"Age Ageing"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/1753-0407.13334","article-title":"Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: a hidden treasure.","volume":"14","author":"Al-Kuraishy","year":"2022","journal-title":"J Diabetes"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"e002787","DOI":"10.1136\/jitc-2021-002787","article-title":"GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.","volume":"9","author":"Wang","year":"2021","journal-title":"J ImmunoTher Cancer"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gendis.2020.02.004","article-title":"Therapeutic potential of TNFalpha inhibitors in chronic inflammatory disorders: past and future.","volume":"8","author":"Zhang","year":"2021","journal-title":"Genes Dis"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.06.018","article-title":"Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes.","volume":"60","author":"Panee","year":"2012","journal-title":"Cytokine"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"e13415","DOI":"10.1111\/acel.13415","article-title":"Exercise reduces circulating biomarkers of cellular senescence in humans.","volume":"20","author":"Englund","year":"2021","journal-title":"Aging Cell"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"e14038","DOI":"10.1111\/acel.14038","article-title":"Calorie restriction reduces biomarkers of cellular senescence in humans.","volume":"23","author":"Aversa","year":"2023","journal-title":"Aging Cell"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5301\/ijao.5000411","article-title":"An intradialytic increase in serum interleukin-6 levels is associated with an increased mortality in hemodialysis patients.","volume":"38","author":"Lichtenberg","year":"2015","journal-title":"Int J Artif Organs"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1159\/000522120","article-title":"Fluctuations in interleukin-6 levels during hemodialysis sessions with medium cutoff membranes: an analysis on COVID-19 case series.","volume":"51","author":"Murt","year":"2022","journal-title":"Blood Purif"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:00:40Z","timestamp":1749060040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005103","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}